Arcus Biosciences, Inc. · NYSE:RCUS

Gilead Sciences, Inc. reported a 24.70% stake in Arcus Biosciences, Inc. (Schedule 13D/A)

Event Aug 5, 2026 · Filed Aug 7, 2026

Gilead Sciences, Inc. reported a 24.70% stake in Arcus Biosciences, Inc., 31,424,760 shares, with active intent on Aug 5, 2026. Filed Aug 7, 2026 (Schedule 13D/A).

Stake
24.70%
Shares
31,424,760
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Gilead Sciences, Inc.24.70%31,424,760

Source

View original at SEC

Related